Gene Review:
Fbxw11 - F-box and WD-40 domain protein 11
Mus musculus
Synonyms:
2310065A07Rik, AA536858, BTRC2, BTRCP2, Btrcp2, ...
- Inhibition of growth of human osteosarcomas by antagonists of growth hormone-releasing hormone. Pinski, J., Schally, A.V., Groot, K., Halmos, G., Szepeshazi, K., Zarandi, M., Armatis, P. J. Natl. Cancer Inst. (1995)
- Inhibition by pentachlorophenol of the initiating and promoting activities of 1'-hydroxysafrole for the formation of enzyme-altered foci and tumors in rat liver. Boberg, E.W., Liem, A., Miller, E.C., Miller, J.A. Carcinogenesis (1987)
- Rapid tumor formation and development of neutrophilia and splenomegaly in nude mice transplanted with human cells expressing human T cell leukemia virus type I or Tax1. Soda, Y., Jinno, A., Tanaka, Y., Akagi, T., Shimotohno, K., Hoshino, H. Leukemia (2000)
- An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Luu, H.H., Kang, Q., Park, J.K., Si, W., Luo, Q., Jiang, W., Yin, H., Montag, A.G., Simon, M.A., Peabody, T.D., Haydon, R.C., Rinker-Schaeffer, C.W., He, T.C. Clin. Exp. Metastasis (2005)
- Inhibition of proliferation in human MNNG/HOS osteosarcoma and SK-ES-1 Ewing sarcoma cell lines in vitro and in vivo by antagonists of growth hormone-releasing hormone: effects on insulin-like growth factor II. Braczkowski, R., Schally, A.V., Plonowski, A., Varga, J.L., Groot, K., Krupa, M., Armatis, P. Cancer (2002)
- Human recipient cell for oncogene transfection studies. Tainsky, M.A., Shamanski, F.L., Blair, D., Vande Woude, G. Mol. Cell. Biol. (1987)
- Mouse homologue of HOS (mHOS) is overexpressed in skin tumors and implicated in constitutive activation of NF-kappaB. Bhatia, N., Herter, J.R., Slaga, T.J., Fuchs, S.Y., Spiegelman, V.S. Oncogene (2002)
- Somatostatin analog RC-160 inhibits the growth of human osteosarcomas in nude mice. Pinski, J., Schally, A.V., Halmos, G., Szepeshazi, K., Groot, K. Int. J. Cancer (1996)
- Gemcitabine inhibits viability, growth, and metastasis of osteosarcoma cell lines. Ando, T., Ichikawa, J., Okamoto, A., Tasaka, K., Nakao, A., Hamada, Y. J. Orthop. Res. (2005)
- Induction of morphological transformation, anchorage-independent growth and plasminogen activators in non-tumorigenic human osteosarcoma cells by lead chromate. Sidhu, M.K., Fernandez, C., Khan, M.Y., Kumar, S. Anticancer Res. (1991)
- Inhibition of HOS expression and activities by Wnt pathway. Spiegelman, V.S., Tang, W., Katoh, M., Slaga, T.J., Fuchs, S.Y. Oncogene (2002)
- Neoplastic transformation of human osteoblast cells to the tumorigenic phenotype by heavy metal-tungsten alloy particles: induction of genotoxic effects. Miller, A.C., Mog, S., McKinney, L., Luo, L., Allen, J., Xu, J., Page, N. Carcinogenesis (2001)
- Meloxicam inhibits osteosarcoma growth, invasiveness and metastasis by COX-2-dependent and independent routes. Naruse, T., Nishida, Y., Hosono, K., Ishiguro, N. Carcinogenesis (2006)
- Characterization of receptors for growth hormone-releasing hormone in human osteosarcomas and Ewing's sarcomas. Halmos, G., Schally, A.V., Bernardino, A.L., Varga, J.L. Int. J. Oncol. (2006)
- Evidence of downregulation of matrix extracellular phosphoglycoprotein during terminal differentiation in human osteoblasts. Siggelkow, H., Schmidt, E., Hennies, B., Hüfner, M. Bone (2004)
- Human osteosarcoma-derived cell lines produce soluble factor(s) that induces differentiation of blood monocytes to osteoclast-like cells. Miyamoto, N., Higuchi, Y., Mori, K., Ito, M., Tsurudome, M., Nishio, M., Yamada, H., Sudo, A., Kato, K., Uchida, A., Ito, Y. Int. Immunopharmacol. (2002)
- Reduction of spermatogenesis and steroidogenesis in mice after fentin and fenbutatin administration. Reddy, P.S., Pushpalatha, T., Reddy, P.S. Toxicol. Lett. (2006)